Skip to Main content Skip to Navigation
Journal articles

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?

Abstract : The clinical benefit of immune checkpoint inhibitory therapy (ICT) in advanced melanomas is limited by primary and acquired resistance. The molecular determinants of the resistance have been extensively studied, but these discoveries have not yet been translated into therapeutic benefits. As such, a paradigm shift in melanoma treatment, to surmount the therapeutic impasses linked to the resistance, is an important ongoing challenge.This review outlines the multifaceted interplay between microphthalmia-associated transcription factor (MITF), a major determinant of the biology of melanoma cells, and the immune system. In melanomas, MITF functions downstream oncogenic pathways and microenvironment stimuli that restrain the immune responses. We highlight how MITF, by controlling differentiation and genome integrity, may regulate melanoma-specific antigen expression by interfering with the endolysosomal pathway, KARS1, and antigen processing and presentation. MITF also modulates the expression of coinhibitory receptors, i.e., PD-L1 and HVEM, and the production of an inflammatory secretome, which directly affects the infiltration and/or activation of the immune cells.Furthermore, MITF is also a key determinant of melanoma cell plasticity and tumor heterogeneity, which are undoubtedly one of the major hurdles for an effective immunotherapy. Finally, we briefly discuss the role of MITF in kidney cancer, where it also plays a key role, and in immune cells, establishing MITF as a central mediator in the regulation of immune responses in melanoma and other cancers.We propose that a better understanding of MITF and immune system intersections could help in the tailoring of current ICT in melanomas and pave the way for clinical benefits and long-lasting responses.
Document type :
Journal articles
Complete list of metadata
Contributor : BERTOLOTTO-BALLOTTI BERTOLOTTO-BALLOTTI Connect in order to contact the contributor
Submitted on : Thursday, February 11, 2021 - 1:55:01 PM
Last modification on : Saturday, June 25, 2022 - 11:49:45 PM
Long-term archiving on: : Wednesday, May 12, 2021 - 6:53:04 PM


Publisher files allowed on an open archive




Robert Ballotti, yann Cheli, Corine Bertolotto. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?. Molecular Cancer, BioMed Central, 2020, 19 (1), pp.170. ⟨10.1186/s12943-020-01290-7⟩. ⟨inserm-03138744⟩



Record views


Files downloads